Other actives

Bakuchiol

INCI: Bakuchiol · retinol alternative

Potentially useful for people prioritizing gentleness, but not an evidence-equivalent replacement for retinoids.

What it is best suited for

What result is realistic

A realistic improvement is possible with consistent use, but response varies by formula and context.

Initial change
Several weeks
When to evaluate
About 8–12 weeks
Expected benefit
Subtle

What it is and what we know

A well-marketed botanical active with early signals for photoaging, but it should not be treated as evidence-equivalent to retinoids.

Its usefulness depends on the goal, vehicle, concentration context, frequency, and the rest of the routine.

Who may find it irritating

Irritation potential: Low. Formula, frequency, and barrier condition change tolerability.

Evidence or guidance may vary by context. Ask a qualified clinician during pregnancy or breastfeeding. It is not modeled as inherently photosensitizing; sun protection still matters for most skin goals.

How a beginner can introduce it

Introduce consistently in a simple routine and adjust to tolerance.

Useful concentration depends on the ingredient form and complete formula. Ingredient order alone cannot establish a studied concentration.

What not to expect

No single ingredient guarantees a result or compensates for an irritating, inconsistent routine.

Ingredient evidence does not guarantee that every product formula performs equally.

What may duplicate it

Other actives is its functional family. Several products from this family can repeat the same role, especially when they are irritation-prone.

Same family: Niacinamide.

Verified products containing it

No verified product yet

TIER does not recommend a formula without an official source. Compare the next-ranked ingredient while the verified catalogue grows.

View the next alternative

Evidence and uncertainty

Editorial preview. Complete source lists and clinical review are not yet published. TIER therefore avoids “best” claims and does not show a public numeric score.

Fine lines · Emerging
Evidence certainty
Emerging
Editorial confidence
Low
Published sources
0
Status
Editorial preview
Last reviewed
2026-07-14

The priority score combines evidence confidence, expected benefit, tolerability, practicality, time, and relative cost. It is not an efficacy percentage.

Important uncertainty: Ingredient evidence does not guarantee that every product formula performs equally.

Next best alternative

Tretinoin is the next-ranked option for Fine lines. Compare it before adding another active.

Compare alternatives
Commission never changes a ranking.
Goal-specificExplainable prioritiesUncertainty shownNo diagnosis